University of Exeter Research: Losing Control of Gene Activity in Alzheimer’s Disease
Oct 24, 2018
about pioneering research into the mechanisms controlling gene activity in the brain could hold the key to understanding Alzheimer’s disease and might help identify effective treatments in the future.
Gamaleya Vaccine Approved: In Unprecedented Race to Approved Vaccine, did Russia ‘Win’?
A Political Ping Pong: Duke HERO Study Still Pursuing Question Whether Hydroxychloroquine a Potential Prophylaxis to COVID-19
Tata Main Hospital Picks Up Ivermectin/Doxycycline Combo Regimen to Address COVID-19
Russia Seeks to Distribute its Accelerated Gamaleya Vaccine to the Philippines
U.S. Operation Warp Speed Offers Loose Money and Opacity; EU Appears to Focus on Loans
Northern Indian State of Uttar Pradesh Drops Hydroxychloroquine & Replaces with Ivermectin for COVID-19 Patients
Advertise with us today!
24/7 News Feed
Osmotica Pharmaceuticals plc Reports Second Quarter 2020 Results and Provides Business Updates
AZTherapies Announces the Appointment of Drs. Robert Malenka, Adam Boxer, Vijay Kuchroo and Megan Levings, to Scientific Advisory Board
BeyondSpring Initiates Expanded Access Program with Plinabulin for Patients Suffering from CIN in the U.S.
aTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Proceeds to Phase 1 Trial of ATYR1923 in Japan
Verrica Pharmaceuticals Licenses LTX-315, A First-in-Class Oncolytic Peptide Based Immunotherapy, from Lytix Biopharma AS, for the Treatment of Dermatologic Oncology Indications
AMRYT PHARMA NOTIFICATION OF CANCELLATION OF ADMISSION TO EURONEXT GROWTH
Pin It on Pinterest